Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD

Gut

Volumn 67, Issue 1, 2018, Pages 70-78

  Carballal, Sabela ^a   Maisterra, Sandra ^b   López Serrano, Antonio ^c   Gimeno García, Antonio Z ^d   Vera, María Isabel ^e   Marín Garbriel, José Carlos ^f   DÍaz Tasende, José ^f   Márquez, Lucía ^g   Álvarez, Marco Antonio ^g   Hernández, Luis ^h   De Castro, Luisa ⁱ   Gordillo, Jordi ^j   Puig, Ignasi ^k   Vega, Pablo ^l   Bustamante Balén, Marco ^m   Acevedo, Juan ⁿ   Peñas, Beatriz ^o   López Cerón, María ^a   Ricart, Elena ^a   Cuatrecasas, Miriam ^a   Jimeno, Mireya ^a   Pellisé, María ^a   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^d HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g HOSPITAL DEL MAR   (Spain)

^h HOSPITAL DE MÓSTOLES   (Spain)

ⁱ UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^j HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^k Althaia   (Spain)

^l Unidad de Enfermedades Infecciosas   (Spain)

^m HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁿ Hospital de Calella   (Spain)

^o HOSPITAL RAMÓN Y CAJAL   (Spain)

more..

Author keywords

COLONOSCOPY; COLORECTAL CANCER; DYSPLASIA; INFLAMMATORY BOWEL DISEASE; ULCERATIVE COLITIS

Indexed keywords

INDIGO CARMINE; COLORING AGENT;

ADULT; ARTICLE; CHROMOENDOSCOPY; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYSPLASIA; ENDOSCOPIST; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; LEARNING CURVE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WHITE LIGHT ENDOSCOPY; AGED; CLINICAL COMPETENCE; CLINICAL TRIAL; COLORECTAL TUMOR; COMPLICATION; CROHN DISEASE; EARLY CANCER DIAGNOSIS; EDUCATION; MEDICAL EDUCATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PRECANCER; PROCEDURES; STANDARDS; ULCERATIVE COLITIS;

ADULT; AGED; CLINICAL COMPETENCE; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORING AGENTS; CROHN DISEASE; EARLY DETECTION OF CANCER; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; INDIGO CARMINE; INFLAMMATORY BOWEL DISEASES; LEARNING CURVE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES;

EID: 84987792452     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312332     Document Type: Article

References (34)

1. Morson BC, Pang LS. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
2. Rubin DT, Rothe JA, Hetzel JT, et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 2007;65:998-1004.
3. Rutter MD, Saunders BP, Wilkinson KH, et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004;60:334-9.
4. van den Broek FJ, Stokkers PC, Reitsma JB, et al. Random biopsies taken during colonoscopic surveillance of patients with longstanding ulcerative colitis: low yield and absence of clinical consequences. Am J Gastroenterol 2014;109:715-22.
5. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
6. Kiesslich R, Goetz M, Lammersdorf K, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 2007;132:874-82.
7. Subramanian V, Mannath J, Ragunath K, et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:304-12.
8. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
9. Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013;7:1-33.
10. Kamiski MF, Hassan C, Bisschops R, et al. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2014;46:435-49.
11. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015;148:639-51. e28.
12. Marion JF, Sands BE. The SCENIC consensus statement on surveillance and management of dysplasia in inflammatory bowel disease: praise and words of caution. Gastroenterology 2015;148:462-7.
13. Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, et al. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol 2015;110:1014-21.
14. Rex DK, Kahi C, O'Brien M, et al. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on real-time endoscopic assessment of the histology of diminutive colorectal polyps. Gastrointest Endosc 2011;73:419-22.
15. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763-86.
16. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77(Pt 2): 843-6.
17. Lai EJ, Calderwood AH, Doros G, et al. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc 2009;69(Pt 2):620-5.
18. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353: 2462-76.
19. Rutter M, Bernstein C, Matsumoto T, et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004;36:1109-14.
20. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003;58(6 Suppl):S3-43.
21. Kudo S, Rubio CA, Teixeira CR, et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 2001;33:367-73.
22. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
23. Mooiweer E, van der Meulen AE, van Bodegraven AA, et al. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines. Inflamm Bowel Dis 2013;19:2603-10.
24. Kiesslich R, Neurath MF. Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight. Gut 2004;53:165-7.
25. Choi CH, Rutter MD, Askari A, et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am J Gastroenterol 2015;110:1022-34.
26. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008;103:2342-9.
27. Matsumoto T, Nakamura S, Jo Y, et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003;98:1827-33.
28. Rutter MD, Saunders BP, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
29. Günther U, Kusch D, Heller F, et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis 2011;26:667-72.
30. Hlavaty T, Huorka M, Koller T, et al. Colorectal cancer screening in patients with ulcerative and Crohn's colitis with use of colonoscopy, chromoendoscopy and confocal endomicroscopy. Eur J Gastroenterol Hepatol 2011;23: 680-9.
31. Picco MF, Pasha S, Leighton JA, et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis 2013;19:1913-20.
32. Subramanian V, Ramappa V, Telakis E, et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013;19:350-5.
33. Tharian B, George N, Navaneethan U. Endoscopy in the diagnosis and management of complications of inflammatory bowel disease. Inflamm Bowel Dis 2016;22:1184-97.
34. Gasia MF, Ghosh S, Panaccione R, et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol 2016;14:704-12. e4.